Fusion Antibodies plc (FAB)の価格はいくらですか

Fusion Antibodies plc (FAB)の価格は$0.1559364です

Fusion Antibodies plc (FAB)の時価総額は何ですか

Fusion Antibodies plc (FAB)の時価総額は$195.17Kです

Fusion Antibodies plc（FAB）の株価履歴

Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.

年	パフォーマンス
2026 (TTM)	-10.83%
2025	153.72%
2024	39.11%
2023	-88.99%
2022	-66.99%
2021	-1.91%
2020	55.79%
2019	51.91%
2018	-71.85%
2017	0.00%

年

パフォーマンス

2026 (TTM)

-10.83%

2025

153.72%

2024

39.11%

2023

-88.99%

2022

-66.99%

2021

-1.91%

2020

55.79%

2019

51.91%

2018

-71.85%

2017

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$509.53	32.99%	US
Argenx SE ARGX.US	$991.92	34.63%	NL
Moderna, Inc. MRNA.US	$154.28	511.26%	US
CSL Limited CSL.AX	$123.40	-5.68%	AU
Lonza Group AG LONN.SW	$708.28	3.70%	CH

企業

株価

変化率 1年%

国